The competition, page-122

This is about a quality technology, which has the potential to revolutionise POC diagnostic testing. If you don't believe in it, why not exit and leave it to the believers to sink or swim by themselves.

Because it's the same old story, we take too bloody long to do anything and then miss the opportunities. Potential? The company has bags of it and always has. The issue is how to commercialise successfully. So far they're really shit at doing that.

I don't want to invest in any old crap test that will be obsolete in a few months time.

But it's not a binary situation is it? ADO could have launched a pretty good product far more decent than the others AND then improved it to gold standard.

That would be taking advantage of the pandemic. Anathema to the mob in charge of the company who just don't understand that most successful companies do just that!
Instead it's dithering and holding fast to a non-commercial position.
They're genius at that.